Congratulations to @profmarkfaghy.bsky.social, LCK Trustee, and his research team.
The ERASE_LC trial evaluated whether a 5-day course of intravenous remdesivir is feasible, safe, and acceptable for people living with Long COVID. (Adults)
@longcovidkids.bsky.social